Home β€Ί Healthcare β€Ί Drug Pipeline β€Ί Global Oncology Drug Market

Global Oncology Drug Market Size, Share, Opportunities, And Trends By Type of Cancer (Lung Cancer, Blood Cancer, Breast Cancer, Liver Cancer, Others), And By Geography - Forecasts From 2025 To 2030

πŸ“₯ Download Free SampleπŸ’¬ Speak to Analyst
$3,950
Single User License
Access Full Insights
Report OverviewSegmentationTable of ContentsCustomize Report

Table of Contents

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

2.1. Market Overview

2.2. Market Definition

2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities

3.4. Porter’s Five Forces Analysis

3.5. Industry Value Chain Analysis

3.6. Policies and Regulations

3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. ONCOLOGY DRUG MARKET BY THERAPY TYPE

5.1. Introduction

5.2. Chemotherapy

5.3. Targeted Therapy

5.4. Immunotherapy

5.5. Hormone Therapy

5.6. Biosimilars

5.7. Others

6. ONCOLOGY DRUG MARKET BY TYPE OF CANCER

6.1. Introduction

6.2. Lung Cancer

6.3. Colorectal Cancer

6.4. Prostate Cancer

6.5. Blood Cancer

6.6. Breast Cancer

6.7. Liver Cancer

6.8. Cervical and Ovarian Cancer

6.9. Others

7. ONCOLOGY DRUG MARKET BY DISTRIBUTION CHANNEL

7.1. Introduction

7.2. Hospital Pharmacies

7.3. Retail Pharmacies

7.4. Online Pharmacies

7.5. Specialty Clinics and Cancer Centers

8. ONCOLOGY DRUG MARKET BY GEOGRAPHY

8.1. Introduction

8.2. North America

8.2.1. USA

8.2.2. Canada

8.2.3. Mexico

8.3. South America

8.3.1. Brazil

8.3.2. Argentina

8.3.3. Others

8.4. Europe

8.4.1. Germany

8.4.2. France

8.4.3. United Kingdom

8.4.4. Spain

8.4.5. Others

8.5. Middle East and Africa

8.5.1. Saudi Arabia

8.5.2. UAE

8.5.3. Others

8.6. Asia Pacific

8.6.1. China

8.6.2. India

8.6.3. Japan

8.6.4. South Korea

8.6.5. Indonesia

8.6.6. Thailand

8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

9.1. Major Players and Strategy Analysis

9.2. Market Share Analysis

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Competitive Dashboard

10. COMPANY PROFILES

10.1. AbbVie Inc.

10.2. F. Hoffmann-La Roche Ltd.

10.3. Novartis AG

10.4. AstraZeneca plc

10.5. Johnson & Johnson Services, Inc.

10.6. Bayer AG

10.7. Merck & Co., Inc.

10.8. Astellas Pharma Inc.

10.9. Pfizer Inc.

10.10. Bristol-Myers Squibb Company

10.11. Eli Lilly and Company

11. APPENDIX

11.1. Currency

11.2. Assumptions

11.3. Base and Forecast Years Timeline

11.4. Key Benefits for Stakeholders

11.5. Research Methodology

11.6. Abbreviations

REPORT DETAILS

Report ID:KSI061613445
Published:May 2025
Pages:141
Format:PDF, Excel, PPT, Dashboard
πŸ“₯ Download SampleπŸ“ž Speak to AnalystπŸ“§ Request Customization

Need Assistance?

Our research team is available to answer your questions.

Contact Us